- Home
- AORT vs CHY Comparison
AORT vs CHY Comparison
Compare AORT & CHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AORT
- CHY
- Stock Information
- Founded
- AORT 1984
- CHY 2003
- Country
- AORT United States
- CHY United States
- Employees
- AORT N/A
- CHY N/A
- Industry
- AORT Medical/Dental Instruments
- CHY Investment Managers
- Sector
- AORT Health Care
- CHY Finance
- Exchange
- AORT Nasdaq
- CHY Nasdaq
- Market Cap
- AORT 1.0B
- CHY 934.9M
- IPO Year
- AORT 1993
- CHY N/A
- Fundamental
- Price
- AORT $24.69
- CHY $10.17
- Analyst Decision
- AORT Strong Buy
- CHY
- Analyst Count
- AORT 5
- CHY 0
- Target Price
- AORT $31.40
- CHY N/A
- AVG Volume (30 Days)
- AORT 470.9K
- CHY 128.3K
- Earning Date
- AORT 05-05-2025
- CHY 01-01-0001
- Dividend Yield
- AORT N/A
- CHY 10.11%
- EPS Growth
- AORT N/A
- CHY N/A
- EPS
- AORT N/A
- CHY N/A
- Revenue
- AORT $388,537,000.00
- CHY N/A
- Revenue This Year
- AORT $11.21
- CHY N/A
- Revenue Next Year
- AORT $10.77
- CHY N/A
- P/E Ratio
- AORT N/A
- CHY N/A
- Revenue Growth
- AORT 9.76
- CHY N/A
- 52 Week Low
- AORT $19.36
- CHY $9.97
- 52 Week High
- AORT $32.33
- CHY $12.16
- Technical
- Relative Strength Index (RSI)
- AORT 42.53
- CHY 33.77
- Support Level
- AORT $23.69
- CHY $10.27
- Resistance Level
- AORT $25.02
- CHY $10.60
- Average True Range (ATR)
- AORT 0.58
- CHY 0.17
- MACD
- AORT 0.25
- CHY 0.01
- Stochastic Oscillator
- AORT 83.02
- CHY 35.82
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
About CHY Calamos Convertible and High Income Fund
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high yield securities.